Glenmark Life Sciences
₹822.55
-11.45 (-1.37%)
18 May, 2024 15:44 BSE: 543322
NSE: GLSISIN: INE03Q201024
Start SIP in Glenmark Life Sciences
Start SIPGlenmark Life Sciences Performance
Day Range
- Low 817
- High 840
52 Week Range
- Low 513
- High 906
- Open Price834
- Previous Close834
- Volume8446
Glenmark Life Sciences Financials
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|
Oper Rev Qtr Cr | 537 | 573 | 595 | 578 | 621 |
Operating Expenses Qtr Cr | 395 | 400 | 428 | 385 | 415 |
Operating Profit Qtr Cr | 141 | 173 | 167 | 193 | 206 |
Depreciation Qtr Cr | 15 | 13 | 13 | 13 | 12 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 32 | 42 | 40 | 47 | 51 |
Net Profit Qtr Cr | 98 | 119 | 119 | 135 | 146 |
Glenmark Life Sciences Technicals
EMA & SMA
Current Price
₹822.55
-11.45 (-1.37%)
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹820.60
- 50 Day
- ₹808.18
- 100 Day
- ₹780.56
- 200 Day
- ₹720.77
- 20 Day
- ₹822.56
- 50 Day
- ₹793.34
- 100 Day
- ₹795.74
- 200 Day
- ₹713.68
Glenmark Life Sciences Resistance and Support
PIVOT
₹832.9
Resistance | |
---|---|
First Resistance | 840.75 |
Second Resistance | 847.50 |
Third Resistance | 855.35 |
RSI | 55.65 |
MFI | 65.24 |
MACD Single Line | 7.59 |
MACD | 6.79 |
Support | |
---|---|
First Support | 826.15 |
Second Support | 818.30 |
Third Supoort | 811.55 |
Glenmark Life Sciences Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 30,658 | 1,762,222 | 57.48 |
Week | 48,037 | 2,740,522 | 57.05 |
1 Month | 138,968 | 6,452,273 | 46.43 |
6 Month | 175,371 | 10,417,064 | 59.4 |
Glenmark Life Sciences Result Highlights
Glenmark Life Sciences Synopsis
NSE-Medical-Ethical Drugs
Glenmark Life Scienc is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 2283.21 Cr. and Equity Capital is Rs. 24.51 Cr. for the Year ended 31/03/2024. Glenmark Life Sciences Ltd. is a Public Limited Listed company incorporated on 23/06/2011 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74900PN2011PLC139963 and registration number is 139963.Market Cap | 10,219 |
Sales | 2,283 |
Shares in Float | 2.08 |
No of funds | 88 |
Yield | 2.72 |
Book Value | 4.38 |
U/D Vol ratio | 1.2 |
LTDebt / Equity | |
Alpha | 0.11 |
Beta | 0.78 |
Glenmark Life Sciences Shareholding Pattern
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 82.85% | 82.85% | 82.85% | 82.85% |
Mutual Funds | 0.93% | 0.59% | 0.38% | 0.52% |
Insurance Companies | 0.15% | |||
Foreign Portfolio Investors | 5.01% | 4.57% | 4.39% | 3.27% |
Financial Institutions/ Banks | ||||
Individual Investors | 9.09% | 9.2% | 9.21% | 10.02% |
Others | 2.12% | 2.79% | 3.02% | 3.34% |
Glenmark Life Sciences Management
Name | Designation |
---|---|
Mr. Glenn Saldanha | Chairman & Non-Exe.Director |
Dr. Yasir Rawjee | Managing Director & CEO |
Mr. Vinod Naik | Executive Director |
Mr. V S Mani | Non Executive Director |
Mr. Sridhar Gorthi | Independent Director |
Mrs. Manju Agarwal | Independent Director |
Mr. Taruvai Laxminarayanan Easwar | Independent Director |
Ms. Gita Nayyar | Independent Director |
Glenmark Life Sciences Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Glenmark Life Sciences Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-04-25 | Audited Results | |
2024-01-23 | Quarterly Results | |
2023-10-20 | Quarterly Results | |
2023-10-09 | Interim Dividend | |
2023-07-21 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-10-17 | INTERIM | Rs.22.50 per share(1125%)Interim Dividend |
2023-03-24 | INTERIM | Rs.21.00 per share(1050%)Interim Dividend |
2021-11-23 | INTERIM | Rs.10.50 per share(525%)Interim Dividend |
Glenmark Life Sciences FAQs
What is Share Price of Glenmark Life Sciences ?
Glenmark Life Sciences share price is ₹822 As on 18 May, 2024 | 15:30
What is the Market Cap of Glenmark Life Sciences ?
The Market Cap of Glenmark Life Sciences is ₹10078.5 Cr As on 18 May, 2024 | 15:30
What is the P/E ratio of Glenmark Life Sciences ?
The P/E ratio of Glenmark Life Sciences is 21.4 As on 18 May, 2024 | 15:30
What is the PB ratio of Glenmark Life Sciences ?
The PB ratio of Glenmark Life Sciences is 4.3 As on 18 May, 2024 | 15:30